NOTCH1 and acute lymphoblastic leukemia: Activating NOTCH1 mutations are present in 60–70% of T-ALL cases [3], with inactivating mutations in FBXW7, a negative regulator of Notch signaling, present in an additional 15% of patients [4–8].